Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with β-thalassemia

被引:15
|
作者
Spoulou, Vana [1 ]
Tzanakaki, Georgina [2 ]
Lekka, Sophia [1 ]
Chouliaras, Giorgos [1 ]
Ladis, Vassilis [3 ]
Theodoridou, Maria [1 ]
机构
[1] Univ Athens, Sch Med, Div Infect Dis, Dept Paediat 1, GR-10679 Athens, Greece
[2] Natl Sch Publ Hlth, Natl Meningitis Reference Lab, Athens, Greece
[3] Aghia Sophia Childrens Hosp, Thalassemia Unit, Athens 11527, Greece
关键词
Meningococcal C conjugate vaccine; beta-Thalassemia; Children; Splenectomy; CONJUGATE VACCINE; ANTIBODY;
D O I
10.1016/j.vaccine.2011.03.080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural and vaccine-induced immunity to meningococcus C (MenC) was evaluated in asplenic adolescents and adults with beta-thalassemia. At baseline 19.3% of patients and 22.8% age-matched controls had positive (> 2 mu g/ml) naturally acquired Men C- specific IgG antibodies; patients had a lower probability of having protective SBA compared to controls (OR =21, p = 0.012). MenC conjugate vaccine (MCC) induced protective IgG concentrations in 63% of patients and 90.1% of controls. SBA increased significantly post vaccination and there were no differences between patients and controls; however patients had significantly lower IgG concentrations post vaccination compared to controls (4.52 vs 10.94 mu g/ml. p < 0.001, respectively). A second dose of MCC given to 11 patients who had received MCC in the past induced higher IgG compared to primary response (p =, 0.001). Naturally- and vaccine-induced immunity to MenC is impaired in asplenic beta-thalassemics; a second dose of MCC improves vaccine immunogenicity and is essential for their optimal protection. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4435 / 4438
页数:4
相关论文
共 50 条
  • [1] Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults
    Goldblatt, D
    Borrow, R
    Miller, E
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (03): : 397 - 400
  • [2] Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B
    Plested, J. S.
    Granoff, D. M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (05) : 799 - 804
  • [3] Natural and vaccine-induced immunity against Haemophilus influenzae type b in patients with β-thalassemia
    Spoulou, VI
    Tsoumas, DL
    Ladis, V
    Spentzou, A
    Theodoridou, MC
    VACCINE, 2006, 24 (16) : 3050 - 3053
  • [4] Neisseria meningitidis serogroup B vaccine development
    Caesar, Nicole M.
    Myers, Kenneth A.
    Fan, Xin
    MICROBIAL PATHOGENESIS, 2013, 57 : 33 - 40
  • [5] Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine
    de Voer, Richarda M.
    Mollema, Liesbeth
    Schepp, Rutger M.
    de Greeff, Sabine C.
    van Gageldonk, Pieter G. M.
    de Melker, Hester E.
    Sanders, Elisabeth A. M.
    Berbers, Guy A. M.
    van der Klis, Fiona R. M.
    PLOS ONE, 2010, 5 (08):
  • [6] Towards an improved serogroup B Neisseria meningitidis vaccine
    Perrett, KP
    Pollard, AJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (12) : 1611 - 1625
  • [7] A Challenge in Vaccine Development - Neisseria meningitidis Serogroup B
    Kim, Jerome H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (03): : 275 - 278
  • [8] Development of natural immunity to Neisseria meningitidis
    Pollard, AJ
    Frasch, C
    VACCINE, 2001, 19 (11-12) : 1327 - 1346
  • [9] A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty
    Andrews, Sophie M.
    Pollard, Andrew
    LANCET INFECTIOUS DISEASES, 2014, 14 (05): : 426 - 434
  • [10] Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B
    Schmiel, Deborah H.
    Moran, Elizabeth E.
    Keiser, Paul B.
    Brandt, Brenda L.
    Zollinger, Wendell D.
    INFECTION AND IMMUNITY, 2011, 79 (10) : 4146 - 4156